These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24 related articles for article (PubMed ID: 1693543)
1. A polypeptide from shark troponin I can inhibit angiogenesis and tumor growth. Xie Q; Yao S; Chen X; Xu L; Peng W; Zhang L; Zhang Q; Liang XF; Hong A Mol Biol Rep; 2012 Feb; 39(2):1493-501. PubMed ID: 21750912 [TBL] [Abstract][Full Text] [Related]
2. Troponin I peptide (Glu94-Leu123), a cartilage-derived angiogenesis inhibitor: in vitro and in vivo effects on human endothelial cells and on pancreatic cancer. Kern BE; Balcom JH; Antoniu BA; Warshaw AL; Fernández-del Castillo C J Gastrointest Surg; 2003 Dec; 7(8):961-8; discussion 969. PubMed ID: 14675705 [TBL] [Abstract][Full Text] [Related]
3. Antiangiogenic properties of a novel shark cartilage extract: potential role in the treatment of psoriasis. Dupont E; Savard PE; Jourdain C; Juneau C; Thibodeau A; Ross N; Marenus K; Maes DH; Pelletier G; Sauder DN J Cutan Med Surg; 1998 Jan; 2(3):146-52. PubMed ID: 9479080 [TBL] [Abstract][Full Text] [Related]
4. Shark cartilage contains inhibitors of tumor angiogenesis. Lee A; Langer R Science; 1983 Sep; 221(4616):1185-7. PubMed ID: 6193581 [TBL] [Abstract][Full Text] [Related]
5. Low molecular weight fraction of shark cartilage can modulate immune responses and abolish angiogenesis. Hassan ZM; Feyzi R; Sheikhian A; Bargahi A; Mostafaie A; Mansouri K; Shahrokhi S; Ghazanfari T; Shahabi S Int Immunopharmacol; 2005 Jun; 5(6):961-70. PubMed ID: 15829412 [TBL] [Abstract][Full Text] [Related]
6. Antiproliferative activity of shark cartilage with and without tumor necrosis factor-alpha in human umbilical vein endothelium. McGuire TR; Kazakoff PW; Hoie EB; Fienhold MA Pharmacotherapy; 1996; 16(2):237-44. PubMed ID: 8820467 [TBL] [Abstract][Full Text] [Related]
7. A novel angiogenic inhibitor derived from Japanese shark cartilage (I). Extraction and estimation of inhibitory activities toward tumor and embryonic angiogenesis. Oikawa T; Ashino-Fuse H; Shimamura M; Koide U; Iwaguchi T Cancer Lett; 1990 Jun; 51(3):181-6. PubMed ID: 1693543 [TBL] [Abstract][Full Text] [Related]
8. Shark cartilage extracts as antiangiogenic agents: smart drinks or bitter pills? Gingras D; Renaud A; Mousseau N; Béliveau R Cancer Metastasis Rev; 2000; 19(1-2):83-6. PubMed ID: 11191068 [TBL] [Abstract][Full Text] [Related]
9. Shark cartilage as source of antiangiogenic compounds: from basic to clinical research. González RP; Leyva A; Moraes MO Biol Pharm Bull; 2001 Oct; 24(10):1097-101. PubMed ID: 11642310 [TBL] [Abstract][Full Text] [Related]